ARTICLE | Company News
ZyStor, Symbiontics metabolic deal
December 16, 2004 8:00 AM UTC
Symbiontics (St. Louis, Mo.) granted ZyStor (Milwaukee, Wis.) exclusive rights to its glycosylation independent lysosomal technology that is designed to improve the delivery of therapeutics for lysoso...